Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Expected to Post Quarterly Sales of $50.07 Million

Retrieved on: 2021-01-02 09:11:15

Tags for this article:

Click the tags to see associated articles and topics

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Expected to Post Quarterly Sales of $50.07 Million. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 1,907,601 shares of the specialty pharmaceutical company's stock valued at $81,034,000 after acquiring an additional ...

Article found on: www.marketbeat.com